Metastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Metastatic Intimal Sarcoma of the Pulmonary Artery Sensitive to Carboplatin-Vinorelbine Chemotherapy: Case Report and Literature Review ; volume:11 ; number:1 ; year:2018 ; pages:21-28
Case reports in oncology ; 11, Heft 1 (2018), 21-28
- Creator
-
Cantaloube, Marie
Moureau-Zabotto, Laurence
Mescam, Lena
Monneur, Audrey
Deluca, Valeria
Guiramand, Jerome
Perrot, Delphine
Bertucci, François
- DOI
-
10.1159/000485740
- URN
-
urn:nbn:de:101:1-201805242122
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cantaloube, Marie
- Moureau-Zabotto, Laurence
- Mescam, Lena
- Monneur, Audrey
- Deluca, Valeria
- Guiramand, Jerome
- Perrot, Delphine
- Bertucci, François
Other Objects (12)
Metastatic biomarkers in synovial sarcoma
Metastatic Ewing's Sarcoma in Right Colon
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
ERBB 4 confers metastatic capacity in Ewing sarcoma
Primary hepatic embryonal sarcoma masquerading as metastatic ovarian cancer
Alternative Chemotherapy Schedules in Ewing's Sarcoma: An Indian Perspective
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Survival after heart transplantation for non-metastatic primary cardiac sarcoma
Metastatic biomarkers in synovial sarcoma
Metastatic Ewing's Sarcoma in Right Colon
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
ERBB 4 confers metastatic capacity in Ewing sarcoma
Primary hepatic embryonal sarcoma masquerading as metastatic ovarian cancer
Alternative Chemotherapy Schedules in Ewing's Sarcoma: An Indian Perspective
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer
Survival after heart transplantation for non-metastatic primary cardiac sarcoma
Metastatic biomarkers in synovial sarcoma
Metastatic Ewing's Sarcoma in Right Colon
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma
Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer
Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma
ERBB 4 confers metastatic capacity in Ewing sarcoma
Primary hepatic embryonal sarcoma masquerading as metastatic ovarian cancer
Alternative Chemotherapy Schedules in Ewing's Sarcoma: An Indian Perspective
Non-chemotherapy adjuvant agents in TP53 mutant Ewing sarcoma
Chemotherapy-induced nausea and vomiting (CINV) with carboplatin plus pemetrexed or carboplatin plus paclitaxel in patients with lung cancer: a propensity score-matched analysis
Androgen receptor pathway inhibitors vs. docetaxel chemotherapy for metastatic hormone-sensitive and first-line castration resistant prostate cancer